OVERVIEW
Building a World-Class Workforce
Pharma must cope with the challenges of recruiting, training, and developing new leadership—and filling some pretty big shoes—amid fierce competition.
Sibyl Shalo, Senior Editor
Confessions of a Corporate Headhunter
After 30 years in the business, a veteran recruiter realizes her profession is broken and suggests being more client-focused as a fix.
Denise DeMan Williams
Bench International
Candidate Care
Even if you don't hire them, treat job applicants as VIPs or suffer the "tell 10 people" consequences.
Bob Hennessey
The Hennessey Group
Found in Translation
Pharma's global expansion has introduced new challenges to building teams across cultures and languages. Here are 12 practical tips to overcome them.
Jorge Arteaga, MD
Alter Translation Services
Educational Exchange
Partner with an institution of higher learning, and reap the rewards of true symbiosis.
Michelle Reece, CMR Institute
Barbara Lockee, Virginia Tech
MVPs
If you were to lose two to five percent of your employees, who would you protect? Those are your multi-culturally adept "most valuable performers."
William Roiter, EdD,
MVP Research Group
Daniel Williams,
Leadership Communications
Life After Big Pharma
As manager of Korn/Ferry's biotech practice, Stephen Israel sees the future of pharma marketing pros, and it's not necessarily at the top of Big Pharma.
Sibyl Shalo, Senior Editor
The Business Case for Diversity
Abbott Labs is the only pharma company (out of 22) to place within the top ten most diverse companies in
DiversityInc
's 2005 Top 50 competition.
Sibyl Shalo,
Senior Editor
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.